肾福康胶囊抑制STAT3/CTGF通路改善大鼠肾间质纤维化的机制研究

Mechanism of rhubarb-astragalus herb pair in ameliorating renal interstitial fibrosis via inhibiting the STAT3/CTGF pathway in rats

  • 摘要: 目的:探讨肾福康胶囊(rhubarb-astragalus herb pair,HPRA)抑制大鼠肾间质纤维化(renal interstitial fibrosis,RIF)的作用机制。方法:将48只雄性(Sprague-Dawley,SD)大鼠随机分为假手术组、模型组、HPRA低剂量组、HPRA中剂量组、HPRA高剂量组和阳性对照组(氯沙坦组),每组8只。除假手术组外,其余各组均采用单侧输尿管梗阻(unilateral ureteral obstruction,UUO)建立肾间质纤维化大鼠模型。腹主动脉采血检测大鼠血清肌酐(serum creatinine,Scr)、血尿素氮(blood urea nitrogen,BUN)水平,苏木精—伊红(hematoxylin-eosin,HE)染色观察肾组织病理学变化,免疫组织化学染色法检测大鼠肾组织α-平滑肌肌动蛋白(α-smooth muscle actin,α-SMA)、信号转导与转录激活因子3(signal transducer and activator of transcription3,STAT3)和结缔组织生长因子(connective tissue growth factor,CTGF)蛋白表达,蛋白质免疫印迹(western blotting)法检测大鼠肾组织波形蛋白(vimentin)、Ⅰ型胶原蛋白(collagen typeⅠ,Col-Ⅰ)和磷酸化STAT3(p-STAT3)蛋白表达,实时荧光定量聚合酶链反应(quantitative real-time polymerase chain reaction,RT-qPCR)法检测大鼠肾组织α-SMACol-ⅠvimentinSTAT3CTGF的mRNA表达,免疫荧光双染色法检测大鼠肾组织CTGF+STAT3+共表达情况。结果:与假手术组比较,模型组大鼠肾组织出现肾小管扩张、空泡变性,Scr、BUN水平,肾组织α-SMA、Col-Ⅰ、vimentin、STAT3、CTGF基因及其蛋白表达水平,p-STAT3蛋白表达水平和CTGF+STAT3+共表达比例均升高(均P<0.05)。HPRA各剂量组肾组织病理损伤程度较模型组明显减轻,Scr、BUN水平,α-SMA、vimentin、STAT3、CTGF基因和蛋白表达水平,以及CTGF+STAT3+共表达比例均下降;HPRA中、高剂量组Col-Ⅰ基因和蛋白表达及p-STAT3蛋白表达水平均降低(均P<0.05)。结论:HPRA可显著抑制大鼠RIF进展,可能与其抑制肾组织STAT3/CTGF信号通路有关。

     

    Abstract: Objective: To explore the mechanism by which the rhubarb-astragalus herb pair(HPRA) inhibits renal interstitial fibrosis(RIF) in rats. Methods: Forty-eight male Sprague-Dawley(SD) rats were randomly divided into six groups with 8 rats per group: a sham group, a model group, a low-dose HPRA group, a mediumdose HPRA group, a high-dose HPRA group and a positive control group(losartan group). Except for the sham group, a rat model of RIF was established in all other groups by unilateral ureteral obstruction(UUO). Blood samples were collected from the abdominal aorta to detect the levels of serum creatinine(Scr) and blood urea nitrogen(BUN). Hematoxylin-eosin(HE) staining was used to observe the renal histopathological changes. Immunohistochemistry(IHC) was performed to detect the protein expressions of α-smooth muscle actin(α-SMA), signal transducer and activator of transcription 3(STAT3), and connective tissue growth factor(CTGF) in the rat renal tissues. Western blotting was applied to detect the protein expressions of vimentin, collagen typeⅠ(Col-Ⅰ) and phosphorylated STAT3(p-STAT3) in the rat renal tissues. Quantitative real-time polymerase chain reaction(RT-qPCR) was used to assess the mRNA expressions of α-SMA, Col-Ⅰ, vimentin, STAT3, and CTGF in the rat renal tissues. Double immunofluorescence staining was conducted to evaluate the co-expressions of CTGF+ and STAT3+ in the rat renal tissues. Results: Compared with the sham group, the model group exhibited dilated renal tubules and vacuolar degeneration in the rat renal tissues. Meanwhile, the levels of Scr and BUN, and the mRNA and protein expressions of α-SMA, Col-Ⅰ, vimentin, STAT3 and CTGF, the protein expression level of p-STAT3, as well as the co-expression proportion of CTGF+ and STAT3+ were significantly increased in the model group(P<0.05). All HPRA dose groups showed markedly alleviated renal pathological injury compared with the model group(P<0.05). Meanwhile, the levels of Scr and BUN, the mRNA and protein expressions of α-SMA, vimentin, STAT3 and CTGF, as well as the proportion of CTGF+ and STAT3+ co-expressions were significantly decreased(P<0.05). Conclusion: HPRA can significantly inhibit the progression of RIF in rats, which may be related to its inhibition of the STAT3/CTGF signaling pathway in renal tissue.

     

/

返回文章
返回